Board Meetings for ZYDUSLIFE

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
ZYDUSLIFEZydus Lifesciences Limited31 Jan 2017Resultsto consider inter alia, to approve the un-audited financial results for the quarter / nine months ended on December 31, 2016.
ZYDUSLIFEZydus Lifesciences Limited26 Oct 2016ResultsTo consider inter alia, to approve the un-audited financial results for the quarter / half year ended on September 30, 2016. Company further inform that as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain closed from October 17, 2016 to October 28, 2016 (both days inclusive) for all the connected persons.
ZYDUSLIFEZydus Lifesciences Limited03 Aug 2016ResultsTo consider inter alia, to approve the un-audited financial results for the quarter ended on June 30, 2016. Company further informed that as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain closed from July 25, 2016 to August 5, 2016 (both days inclusive) for all the connected persons.
ZYDUSLIFEZydus Lifesciences Limited13 May 2016Raising of FundsThe Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held on May 13, 2016 To consider amongst other agenda items to approve the audited financial results for the year ended on March 31, 2016. the company has now inform the exchange that the Board of Directors at its meeting to be held on May 13, 2016 also to consider the following proposals for raising funds/ issuance of securities, which will be subject to approval of the members:1) to raise funds by issue of Equity Shares/ convertible Bonds/Debentures through Qualified Institutional placement (QIP)/GDR/ADR for an aggregate amount upto Rs. 10,000 Crores, 2) to issue Secured/Unsecured Redeemable Non-Convertible Debentures on Private placement basis for an amount upto Rs. 3500 Crores in the Financial Year 2016-17, and 3) to issue Secured/Unsecured Foreign Currency Rated Bonds/ Foreign Currency Convertible Bonds for an amount upto Rs.5000 Crores.
ZYDUSLIFEZydus Lifesciences Limited13 May 2016Results/OthersTo consider amongst other agenda items to approve the audited financial results for the year ended on March 31, 2016.
ZYDUSLIFEZydus Lifesciences Limited08 Mar 2016Dividendto consider inter alia, declaration of Interim Dividend for the financial year 2015-16, and to fix the Record Date.
ZYDUSLIFEZydus Lifesciences Limited05 Feb 2016ResultsTo consider inter alia, to approve the un-audited financial results of the Company for the quarter / nine months ended December 31, 2015.
ZYDUSLIFEZydus Lifesciences Limited22 Oct 2015ResultsTo consider amongst other agenda items to approve the unaudited financial results for the quarter/ half-year ended on September 30, 2015.
ZYDUSLIFEZydus Lifesciences Limited12 Aug 2015ResultsTo consider amongst other agenda items to approve the unaudited financial results for the quarter ended on June 30, 2015
ZYDUSLIFEZydus Lifesciences Limited15 May 2015Results/DividendTo consider amongst other agenda items: 1. To approve the audited stand-alone and consolidated financial results for the quarter / year ended on March 31, 2015 2. To recommend the dividend on equity shares of the Company for the financial year ended on March 31, 2015.
-
ZYDUSLIFEZydus Lifesciences Limited10 Feb 2015Results/OthersTo consider amongst other agenda items to approve the unaudited financial results for the quarter and nine months ended on December 31, 2014.
-
ZYDUSLIFEZydus Lifesciences Limited06 Nov 2014ResultsTo consider amongst other agenda items to approve the unaudited financial results for the quarter/ half-year ended on September 30, 2014. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window will remain close from October 27, 2014 to November 07, 2014 for all directors and designated officers of the Company.
-
ZYDUSLIFEZydus Lifesciences Limited30 Jul 2014ResultsTo consider amongst other agenda items to approve the unaudited financial results for the quarter ended on June 30, 2014. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window will remain close from July 21, 2014 to July 31, 2014 for all directors and designated officers of the Company.
-
ZYDUSLIFEZydus Lifesciences Limited16 May 2014Results/DividendInter alia, to approve the audited financial results for the year ended on March 31, 2014 and to recommend the dividend on equity shares o the Company for the year ended on March 31, 2014. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window will remain close from May 09, 2014 to May 17, 2014 for all Directors arid designated officers of the Company.
ZYDUSLIFEZydus Lifesciences Limited07 Feb 2014Results/OthersTo consider amongst other agenda items to approve the unaudited financial results for the quarter/nine months ended on December 31, 2013. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI(Prohibition of inisder Trading) Regulations, 1992, the Trading Window will remain close from January 29, 2014 to February 08, 2014 for all Directors and designated officers of the Company.
-
Showing page 5 of 8 (118 total items)